Fundraising FoxRapha Capital Management, LLC — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Eos SENOLYTIXeossenolytix.comJun 2026
Eos SENOLYTIX develops senolytic peptides designed to restore cellular balance in aged or senescent cells across body organs, focusing on gerotherapeutics.
BiotechHealthtechLongevityHouston, US
Kevin Slawin, M.D.(Founder and CEO)in
BoardJerold Winograd(Director)Frank Bartlett McGuyer(Director)
PartnerKevin M. Slawin· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.